Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

BUZZ

Pharmadrug (BUZZ)

Pharmadrug Inc
Date:
Sort by:
 Showing the most relevant articles for your search:CSE:BUZZ
DateTimeSourceHeadlineSymbolCompany
04/20/20219:41AMInvestorsHub NewsWirePHARMADRUG ADVANCES PRODUCT AND CLINICAL DEVELOPMENT OF CEPHARANTHINE TO TREAT RARE CANCERS AND INFECTIOUS DISEASESCSE:BUZZPharmadrug Inc
03/16/20218:10AMInvestorsHub NewsWirePHARMADRUG INITIATES DMT RESEARCH ACTIVITIES VIA COLLABORATION WITH THE UNIVERSITY OF MICHIGAN FOR FOUNDATIONAL DMT RESEARCHCSE:BUZZPharmadrug Inc
02/25/20218:13AMInvestorsHub NewsWirePHARMADRUG FILES FOR FDA ORPHAN DRUG DESIGNATION FOR DMT IN KIDNEY TRANSPLANTATION AND EXPANDS ON ITS PSYCHEDELICS STRATEGYCSE:BUZZPharmadrug Inc
02/11/20218:18AMInvestorsHub NewsWirePHARMADRUG FILES FOR FDA ORPHAN DRUG DESIGNATION FOR DMT IN STROKECSE:BUZZPharmadrug Inc
02/08/20218:00AMInvestorsHub NewsWirePHARMADRUG APPOINTS WORLD-RENOWNED DMT EXPERT DR. STEVEN A. BARKER TO ITS SCIENTIFIC ADVISORY BOARD...ContCSE:BUZZPharmadrug Inc
02/04/20218:58AMInvestorsHub NewsWirePHARMADRUG SIGNS SUPPLY AGREEMENT WITH GLOBAL CANNABIS SUPPLIER AND PROVIDES UPDATE ON GERMAN OPERATIONSCSE:BUZZPharmadrug Inc
02/02/20218:48AMInvestorsHub NewsWirePHARMADRUG COMPLETES ACQUISITION OF SAIRIYO THERAPEUTICS INC.CSE:BUZZPharmadrug Inc
01/25/20219:01AMInvestorsHub NewsWirePHARMADRUG ENTERS DEFINITIVE AGREEMENT FOR ACQUISITION OF SAIRIYO THERAPEUTICS INC.CSE:BUZZPharmadrug Inc
01/12/20218:40AMInvestorsHub NewsWirePHARMADRUG ANNOUNCES LOI TO ACQUIRE SAIRIYO THERAPEUTICS INCCSE:BUZZPharmadrug Inc
 Showing the most relevant articles for your search:CSE:BUZZ

Your Recent History

Delayed Upgrade Clock